Renal replacement modality and stroke risk in end-stage renal disease-a national registry study.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The risk of stroke in end-stage renal disease (ESRD) on renal replacement therapy (RRT) is up to 10-fold greater than the general population. However, whether this increased risk differs by RRT modality is unclear.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Nephrol. Dial. Transplant.

Title: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Publisher: Oxford University Press (OUP)

ISSN (Electronic): 1460-2385

ISSN (Print): 0931-0509

Publication date (Electronic): September 01 2018

Volume: 33

Issue: 9

Affiliations

[1 ] Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

[2 ] The Glasgow Renal and Transplant Unit, Queen Elizabeth University Hospital, Glasgow, UK.

[3 ] Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.

[4 ] Scottish Stroke Care Audit, ISD, Edinburgh, UK.

[5 ] Department of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.

[6 ] Scottish Renal Registry, ISD, Glasgow, UK.

Article

Publisher Item ID: 4560121

DOI: 10.1093/ndt/gfx291

PubMed ID: 29069522

SO-VID: 0769c2de-0a2a-48e9-98c9-fa6252c3acab

History

Data availability:

Comments

Comment on this article

scite_

Cited by 6

See all cited by